---
title: "Prevalence and correlates of sarcopenia in community-dwelling older adults in Penang, Malaysia"
id: "plos-one-6-prevalence-of-sarcopenia-among-community-dwelling-older-adults-in-an-urban"
canonical_url: "https://medichelpline.com/clinical-feed/plos-one-6-prevalence-of-sarcopenia-among-community-dwelling-older-adults-in-an-urban"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "PLOS ONE (Medicine)"
source_url: "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362968"
published_at: "2026-11-17T14:00:00.000Z"
evidence_level: "Journal Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Prevalence and correlates of sarcopenia in community-dwelling older adults in Penang, Malaysia
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/plos-one-6-prevalence-of-sarcopenia-among-community-dwelling-older-adults-in-an-urban
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** PLOS ONE (Medicine)
- **Source URL:** [Original Journal Publication](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362968)
- **Published At:** 2026-11-17T14:00:00.000Z
- **Evidence Rating:** Journal Feed
## Executive GIST (TL;DR)
- A cross-sectional study enrolled 226 community-dwelling adults aged ≥60 years in Seberang Perai Utara (SPU), Penang, using convenience sampling across six primary-care outreach sites and clinic open days. - Investigators diagnosed **sarcopenia** using the **AWGS 2019** criteria, combining measures of muscle mass, muscle strength, and physical performance. - Overall sarcopenia prevalence was 32.7%: 15.0% met criteria for severe sarcopenia and 17.7% met criteria for sarcopenia. - Muscle mass was assessed by bioelectrical impedance analysis (Inbody 270); handgrip strength and the five-times chair stand test assessed strength and performance. - Multivariable logistic regression identified higher **BMI** as associated with lower odds of sarcopenia (adjusted OR 0.794; 95% CI 0.723–0.873; p < 0.001). - Physical activity level, categorized by IPAQ short form into inactive, minimally active, and **HEPA** active, was significantly associated with sarcopenia (p = 0.013). - Minimally active participants had greater odds of sarcopenia compared with HEPA active participants (adjusted OR 4.393; 95% CI 1.583–12.193; p = 0.004). - Data collection occurred 1–30 September 2025; the study adhered to AWGS 2019 definitions because data collection preceded the AWGS 2025 update. - Investigators noted limitations inherent to the cross-sectional design and convenience sampling that affect causal inference and population representativeness. - The dataset supporting the analysis is publicly available at Universiti Putra Malaysia’s repository as cited in the source article.
## Clinical Analysis & Structured Key Points
Prevalence of sarcopenia among community-dwelling older adults in an urban district in Penang, Malaysia and its associated factors | PLOS One Browse Subject Areas ? Click through the PLOS taxonomy to find articles in your field. For more information about PLOS Subject Areas, click here . Article Authors Metrics Comments Media Coverage Reader Comments Figures Figures Abstract Background Sarcopenia refers to a progressive decline in skeletal muscle mass, strength, and physical performance that commonly occurs with ageing, and is associated with adverse outcomes such as frailty, disability, and mortality. Despite its growing public health importance in ageing populations, limited data are available on the prevalence of sarcopenia in Penang, Malaysia. This study aimed to determine the prevalence of sarcopenia and its associated factors among community-dwelling older adults in an urban district in Penang. Methods A cross-sectional study was conducted among community-dwelling adults aged 60 years and above in the Seberang Perai Utara district, Penang. Participants were recruited using convenience sampling. Sarcopenia was diagnosed using the Asian Working Group for Sarcopenia (AWGS) 2019 criteria based on muscle mass, muscle strength, and physical performance. Data on sociodemographic characteristics, comorbidities, and physical activity levels were collected using a structured questionnaire and the International Physical Activity Questionnaire (IPAQ) short form. Logistic regression analysis was performed to identify factors associated with sarcopenia. Results A total of 226 participants were included in the study. The overall prevalence of sarcopenia was 32.7%, including 15.0% with severe sarcopenia and 17.7% with sarcopenia. In multivariate analysis, higher body mass index (adjusted OR 0.794, 95% CI 0.723–0.873, p < 0.001) was associated with lower odds of sarcopenia. Physical activity level was also significantly associated with sarcopenia (p = 0.013). Participants who were minimally active had higher odds of sarcopenia (adjusted OR = 4.393, 95% CI: 1.583–12.193, p = 0.004) compared with HEPA active participants. Conclusion Sarcopenia was identified in nearly one-third of participants among community-dwelling older adults in Seberang Perai Utara, Penang. Compared with HEPA active participants, minimally active participants were associated with higher odds of sarcopenia. Whereas higher BMI was associated with lower odds of the condition. These findings highlight key cross-sectional correlates of sarcopenia in community, emphasizing the importance of monitoring body weight, muscle health, and physical activity engagement among community-dwelling older adults. Citation: Low SW, See ZH, Abdul Hamid N, Oung WKC, Yusof Y, Chin YW, et al. (2026) Prevalence of sarcopenia among community-dwelling older adults in an urban district in Penang, Malaysia and its associated factors. PLoS One 21(11): e0362968. https://doi.org/10.1371/journal.pone.0362968 Editor: Jeremy P. Loenneke, University of Mississippi, UNITED STATES OF AMERICA Received: March 12, 2026; Accepted: November 2, 2026; Published: November 17, 2026 Copyright: © 2026 Low et al. This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Data Availability: The minimal data set is available at official research data repository platform for Universiti Putra Malaysia via http://putrarepo.upm.edu.my/direct/UPM-NL-269 . Funding: The author(s) received no specific funding for this work. Competing interests: The authors have declared that no competing interests exist. Introduction According to projections by the World Health Organization, the global population aged 60 years and above will increase substantially, reaching approximately one in six individuals by 2030, with the population of this age group increasing from 1 billion in 2020 to 1.4 billion by 2030 and reaching 2.1 billion by 2050 [ 1 ]. Over the past two decades, Malaysia has also experienced a demographic shift towards an ageing population [ 2 ]. According to the Department of Statistics Malaysia (DOSM), Penang is the second fastest-ageing state in the country, with 60 years and above comprising 14.9% of its total population in 2020 [ 3 ]. The ageing population in Penang is projected to grow rapidly, with those aged 60 years and above expected to account for 26.2%, or more than one-quarter of the state’s total population, by 2040 [ 3 ]. According to the WHO, healthy ageing is defined as the process of developing and maintaining the functional ability that enables well-being in older age [ 4 ]. With the increasing proportion of older adults in the population, it is essential to promote healthy ageing through adequate nutrition, healthier lifestyles, strong family and governmental support, and robust social networks. In a 1988 meeting held in Albuquerque, New Mexico, Irwin Rosenberg highlighted that one of the most significant age-related changes is the loss of lean body mass. He emphasized the importance of recognizing this phenomenon and proposed the term “sarcopenia.” The term is derived from the Greek words sarx, meaning flesh, and penia, meaning loss [ 5 ]. The diagnostic framework for sarcopenia in Asia has evolved continuously over the past decade. The Asian Working Group for Sarcopenia (AWGS) in 2014 defines sarcopenia as an age-related decline in skeletal muscle mass together with reduced muscle strength and/or impaired physical performance. Following further evaluation, the AWGS 2019 consensus retained this definition, emphasizing that diagnosis should be based on the assessment of both muscle quantity and muscle quality. Individuals presenting with low muscle mass, low muscle strength, and poor physical performance are classified as having severe sarcopenia [ 6 ]. Most recently, the AWGS 2025 consensus updated this framework by emphasizing concurrent low muscle mass and low muscle strength as the mandatory co-criteria for confirming sarcopenia, while reframing physical performance metrics as functional outcomes and indicators of disease severity. Because our study design and data collection were completed in September 2025 prior to the release of the updated 2025 consensus, case definitions in this study strictly adhered to the established AWGS 2019 criteria [ 7 ]. Globally, the prevalence of sarcopenia ranged from 8% to 36% in individuals <60 years and from 10% to 27% in individuals ≥ 60 years, depending on the population studied and diagnostic criteria used [ 8 ]. In Malaysia, limited studies have examined the prevalence of sarcopenia among community-dwelling older adults. Existing evidence suggests that prevalence varies across regions. A study conducted in Klang Valley reported a prevalence of 33.6% among older adults, whereas a prevalence of 12.5% was observed among Chinese older adults in Kelantan [ 9 , 10 ]. However, no published studies have investigated the prevalence of sarcopenia in Penang. Regionally, Penang presents a critical study setting as it is the second fastest-ageing state in Malaysia by proportion, with individuals aged 60 years and above comprising 14.9% of its total population in 2020, a figure projected to rise sharply to 26.2% by 2040. [ 3 ] Beyond demographic proportion, Penang is one of Malaysia’s most highly urbanized states. This rapid urbanization has driven significant lifestyle transitions among older adults, including increased sedentary behavior, occupational changes, and altered dietary patterns, factors closely linked to age-related muscle deterioration. Despite Penang’s high aging trajectory and distinct urban lifestyle profile, local epidemiological data on muscle health remain absent. Sarcopenia is associated with negative health outcomes such as frailty, disability, hospitalization, and premature mortality; therefore, identifying its clinical correlates is important for community care. [ 11 ] Numerous factors, including inactivity, falls, frailty, comorbidities, body mass index (BMI), nutritional consumption, and malnutrition, have been linked to sarcopenia; however, these findings have not been consistent across all studies. Increasing age has been correlated with higher odds of sarcopenia. A study in China showed that aging was significantly associated with sarcopenia (OR: 1.047, 95% CI: 1.005–1.090) [ 12 ]. Similar findings were shown in Thailand, which found that 6.5% of patients between the ages of 60 and 69, 14.9% of patients between the ages of 70 and 79, and 46.7% of patients above the age of 80 had sarcopenia [ 13 ]. Research indicates that middle-aged adults experience a steady decrease in muscle mass, which accelerates around age 75 [ 13 ]. Meanwhile, another study found that among older people in the United Kingdom, people with sarcopenia were older (OR: 14.19, 95% CI: 11.95–16.86) [ 14 ]. Gender roles in relation to sarcopenia odds have varied across countries. In certain studies, sarcopenia was more frequent in men than in women. This is due to older men’s muscular mass deteriorating more quickly than older women’s, whereas older women’s muscular mass only decreases in the early stages of menopause. In Pakistan, male gender was found to be associated with sarcopenia, with males having 2.63 times higher odds of the condition than females (OR = 2.63, 95% CI: 1.33–5.18, p = 0.005) [ 15 ]. Meanwhile, in Malaysia, the prevalence of sarcopenia was found to be slightly higher among females, 35.9%, as compared to males, 30.1% [ 10 ]. In contrast, among Thai senior outpatients who live in the community, there was no discernible difference in sarcopenia likelihood based on gender. [ 13 ] Higher body mass index (BMI) is inversely associated with sarcopenia. Those with lower BMI have higher odds of sarcopenia (OR: 0.424, 95%CI: 0.346–0.519) [ 12 ]. Our local study evaluating factors associated with sarcopenia among older adults with type 2 diabetes mellitus showed that higher BMI was associated with lower odds of sarcopenia (OR = 0.09; 95%CI = 0.05, 0.16; p < 0.001), with each unit increase in BMI linked to a 9% reduction in odds [ 16 ]. Similar findings exhibited by Altaf et al. observed that higher weight and BMI were associated with lower odds of sarcopenia (OR: 0.89, 95% CI: 0.85–0.92, p < 0.001) (OR: 0.35, 95% CI: 0.20–0.60, p < 0.001) [ 15 ]. Elderly people in Spanish nursing homes who are not obese have higher odds of being diagnosed with sarcopenia than those with obesity (OR: 0.064, 95% CI: 0.004–0.993) (p < 0.020) (OR: 0.11, 95% CI: 0.18–0.65) [ 17 ]. Physical activity and sarcopenia are closely linked, with inactivity being a major correlate of sarcopenia. Low physical activities (OR: 4.638, 95% CI: 1.683–12.782) were significantly associated with sarcopenia among older adults in Taiwan [ 12 ]. Similar results were shown by Kitamura in 2021, where older adults in Japan with low physical activity had higher odds of sarcopenia (OR: 1.4, 95% CI: 1.0–2.0) (p < 0.05) [ 11 ]. Among older adults with type 2 diabetes mellitus in Klang Valley, Malaysia, engaging in low physical activity (OR = 2.15; 95%CI = 1.07, 4.35; p = 0.032) or moderate physical activities (OR = 2.23; 95% CI = 1.07, 4.66; p = 0.033) was associated with higher odds of sarcopenia [ 16 ]. In Malaysia, existing evidence on sarcopenia is geographically limited and reflects distinct regional profiles. However, no published studies have investigated sarcopenia in Penang or the northern region of Peninsular Malaysia. Specifically, the Seberang Perai Utara (SPU) district features a blend of urban and semi-urban communities served by a well-established network of public health clinics, making it an ideal micro-environment to evaluate community-dwelling older adults. This study aims to determine the prevalence and associated factors of sarcopenia among community-dwelling older adults in the Seberang Perai Utara District, Penang. Determining the prevalence and associated factors in this unique population is essential for informing localized public health strategies. Method Study design and setting This study was conducted in the Seberang Perai Utara (SPU) district within the state of Penang, located in northwest Peninsular Malaysia. Penang is an upper-middle-income, highly urbanized state that plays a central economic and healthcare role in northern Malaysia. Geographically, Penang is divided into Penang Island and the mainland territory of Seberang Perai. SPU is the northernmost district on the mainland, anchored by major commercial, industrial, and transportation centres alongside rapidly expanding suburban residential sectors. The SPU district encompasses a multi-ethnic population (primarily Malay, Chinese, and Indian ethnic groups) that reflects the broader demographic structure and epidemiological transition of urbanizing Malaysia. Primary healthcare delivery in SPU is structured around public health clinics operated by the Ministry of Health Malaysia. These primary care centers serve as the main point of contact for routine health screening, chronic disease management, and preventive care for community-dwelling older adults, making them a representative setting for evaluating community sarcopenia burden. This study employed a cross-sectional design and was conducted by research team members from the health clinics underSPU district, Penang, Malaysia. The participating clinics included Klinik Kesihatan Sungai Dua, Klinik Kesihatan Mak Mandin, Klinik Kesihatan Butterworth, Klinik Kesihatan Kepala Batas, Klinik Kesihatan Penaga, and Klinik Kesihatan Tasek Gelugor. Participants were recruited using convenience sampling from eligible individuals during the study period. Study population The study population consisted of community-dwelling individuals aged 60 years and above who had resided in the SPU district for more than one year during the study period. Eligible individuals who fulfilled the inclusion and exclusion criteria were invited to participate. Individuals were excluded if they had severe or uncompensated clinical conditions that directly impaired physical mobility or precluded physical performance testing. These included severe cognitive impairment, advanced physical disability, active neurological deficits (e.g., acute stroke with residual hemiplegia), severe end-stage organ dysfunction (such as symptomatic heart failure, end-stage kidney disease, or severe chronic obstructive pulmonary disease), acute infections, or acute musculoskeletal injuries. Sample size calculation The sample size was calculated based on the study objectives. The largest required sample size was calculated for the association between age and sarcopenia, assuming an odds ratio of 2.45 and a proportion of controls with sarcopenia of 22%, based on the study by Sazlina et al [ 16 ]. With a Type I error probability of 0.05 and a power of 80%, the minimum required sample size was 188 participants. After accounting for a 20% potential non-response rate, the final target sample size was 226 participants. To confirm that the achieved sample size was adequate for multivariable logistic regression analysis, the Events Per Variable (EPV) criterion was evaluated. Based on the recommended minimum of 5–10 events per candidate predictor variable in multivariable logistic regression, proposed by Peduzzi et al. (1996) and relaxed by Vittinghoff & McCulloch (2007), the total number of sarcopenic cases identified in this study (n = 74, prevalence 32.7%) provided sufficient statistical power to evaluate the total 7 predictor parameters entered in the final model. Ethics This study was conducted in accordance with the ethical principles of the Declaration of Helsinki and the Malaysian Good Clinical Practice Guidelines. Ethical approval was obtained from the Medical Research and Ethics Committee (MREC), Ministry of Health Malaysia, through the National Medical Research Register (NMRR ID-25–01861-EMJ (IIR)). All participants were provided with detailed information about the study before participation. Written consent was obtained before completion of the questionnaire. Participation was voluntary, and participants had the right to decline or withdraw at any time without consequence. All data were collected anonymously and treated with strict confidentiality. Access to the data was restricted to the research team, and the data was stored securely to ensure participant privacy. Data collection Data collection was conducted from 1 September 2025–30 September 2025 across all participating clinics until the target sample size was achieved. All the participants were recruited during community outreach programs, clinic open days, and routine health clinic visits. To minimize selection bias and achieve broad district-wide representativeness, a proactive multi-site community sampling approach was implemented across the SPU district during the study period. The research team conducted structured community outreach programs across six major geographic community sectors within SPU. In addition, a dedicated health clinic open day was organized to encourage broader community participation, alongside routine primary health clinic encounters. Eligible participants who fulfilled the inclusion and exclusion criteria were provided with a detailed explanation of the study, and a participant information sheet was distributed. Written informed consent was obtained from those who agreed to participate. Subsequently, participants underwent a face-to-face interview followed by sarcopenia diagnostic assessments. To minimize measurement bias, all physical assessments were conducted using standardized procedures by trained research personnel. Study instruments and measurements A structured data collection form was used to obtain participants’ demographic and clinical information, including age, gender, ethnicity, educational level, employment status, monthly income, and health status. Physical activity level was assessed using the International Physical Activity Questionnaire (IPAQ) – Short Form(SF), which has demonstrated acceptable criterion validity and test-retest reliability. [ 18 ]. Activity was converted to Metabolic Equivalent of Task minutes per week (MET-min/week) according to the IPAQ-SF user guidelines. Participants were subsequently classified into three physical activity levels which are inactive, minimally active, and health-enhancing physically active (HEPA active) based on the standard IPAQ categorization criteria. Sarcopenia diagnostic assessments included measurement of hand grip strength, the five-times chair stand test, height, weight, and body composition analysis. These parameters were used to evaluate muscle strength, physical performance, and muscle mass, in accordance with the AWGS 2019 diagnostic criteria for sarcopenia [ 6 ]. Height was measured to the nearest using a portable stadiometer (Seca 213, Hamburg, Germany) with participants standing barefoot with heels together and head in the Frankfurt horizontal plane. Body Mass Index (BMI) was calculated as . Bioelectrical impedance analysis (BIA) is used to measure weight and assess appendicular skeletal muscle mass (ASM), with a cutoff point of <7.0 kg/m² for males and <5.7 kg/m² for females represents low ASM mass index. The model of the BIA machine used is Inbody 270, Inbody Co., Ltd, Seoul, South Korea. This BIA machine is a validated tool for the quantification of body composition, comparable with whole body dual-energy X-ray absorptiometry (DEXA) scan in adults [ 19 ]. All BIA assessments were performed using a standardized protocol in accordance with the manufacturer’s guidelines and clinical research standards for body composition measurement. Participants were advice to avoid strenuous physical exercise, refrain from consuming caffeine or alcohol, fast or refrain from heavy me
## Related Clinical Research

- [Embolic Stroke and DOAC Failure in Libman-Sacks Endocarditis with Antiphospholipid Syndrome](https://medichelpline.com/clinical-feed/pubmed-43058350.md) (DOI: 10.1007/s00296-026-06331-w)
- [Cardiovascular outcomes of GLP-1 receptor agonists: systematic review findings](https://medichelpline.com/clinical-feed/pubmed-42033237.md) (DOI: 10.1093/ajhp/zxag121)
- [ZEUS trial: IL-6 blocker ziltivekimab lowered inflammation but did not cut major CV events](https://medichelpline.com/clinical-feed/aha-news-1-researchers-say-inflammation-as-a-treatment-target-still-important-despite.md)
- [GLP-1 drugs tied to lower diabetes progression and cardiovascular events than metformin](https://medichelpline.com/clinical-feed/aha-news-4-glp-1-meds-linked-to-lower-diabetes-heart-risks-than-standard-diabetes.md)
- [Comparing BMI, Waist Circumference, and BRI for Predicting ASCVD, AF, and Mortality in 1.2M Koreans](https://medichelpline.com/clinical-feed/plos-one-14-prognostic-associations-of-anthropometric-indices-with-major-health-outcomes-a.md)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.